Table 1.

Participant characteristics by treatment group

	Group 1	Group 2	Group 3	Group 4	Total
N	7	7	7	7	28
Gender (female)	4	5	3	2	14 (50%)
Race—Caucasian	7	7	7	7	28 (100%)
Ethnicity—Hispanic	0	0	1	0	1 (4%)
Age—median (min-max)	47 (17–75)	45 (41–75)	51 (41–75)	59 (14–70)	51 (14–75)
ECOG Performance status 0	7	6	7	7	27 (96%)
Stage IIA	0	1	0	3	4 (14%)
Stage IIB	0	0	0	1	1 (4%)
Stage IIIA	1	1	1	2	5 (18%)
Stage IIIB	0	3	4	0	7 (25%)
Stage IIIC	2	2	2	1	7 (25%)
Stage IV	4	0	0	0	4 (14%)
HLA-A1	5	2	2	1	10 (36%)
HLA-A2	4	5	5	6	20 (71%)
HLA-A3	0	1	0	1	2 (7%)